Sclerosants: A comparative review

Dermatologic Surgery

Volumn 36, Issue SUPPL. 2, 2010, Pages 1010-1025

  Duffy, David M ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Society of Cosmetic Dermatology and Aesthetic Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CORTICOSTEROID; DIPHENHYDRAMINE; MONOETHANOLAMINE OLEATE; MORRHUATE SODIUM; OXYGEN; POLIDOCANOL; SCH 600; SCLEROSING AGENT; SODIUM CHLORIDE; TETRADECYL SULFATE SODIUM; UNCLASSIFIED DRUG;

ANAPHYLAXIS; BREAST FEEDING; CARCINOGENICITY; CARDIOTOXICITY; DEEP VEIN THROMBOSIS; DRUG APPROVAL; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG FATALITY; DRUG FORMULATION; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG SENSITIVITY; DRUG STORAGE; FOOD AND DRUG ADMINISTRATION; HEMOGLOBINURIA; HUMAN; HYPERPIGMENTATION; INJECTION SITE URTICARIA; LUNG EMBOLISM; MEDICAL LITERATURE; MUTAGENICITY; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PAIN; PIGMENT DISORDER; PRIORITY JOURNAL; REVIEW; SCLEROTHERAPY; SYSTEMATIC REVIEW; TERATOGENICITY; TISSUE NECROSIS; VARICOSIS;

CLINICAL TRIALS AS TOPIC; DETERGENTS; DRUG APPROVAL; DRUG INTERACTIONS; DRUG STORAGE; HUMANS; MICROBUBBLES; POLYETHYLENE GLYCOLS; SCLEROSING SOLUTIONS; SCLEROTHERAPY; SODIUM TETRADECYL SULFATE; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; VARICOSE VEINS;

EID: 77952896338     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2009.01469.x     Document Type: Review

References (43)

1. Green D. Theirs BH, Pearson GL Jr., editors. Year book of dermatology and dermatologic surgery.
2. Kobayashi S, Crooks S, Eckmann DM. Dose and time dependent liquid sclerosant effects on endothelial cell death. Dermatol Surg 2006 32 : 1444 1452.
3. Furie B, Furie BC. Mechanisms of thrombus formation. N Engl J Med 2008 359 : 938 949.
4. Artemi P. Mechanism of action of sclerotherapy. Pharmacology of Phlebology ACP Australasian meeting Sept. 2007.
5. Georgiev M. Postsclerotherapy hyperpigmentations. J Dermatol Surg Oncol 1993 19 : 649 652.
6. Duffy D. Techniques of small vessel sclerotherapy. In : Goldman M, Weiss R, Bergan J, editors. Varisose veins and telangiectasia: diagnosis and treatment. 2nd Ed.
7. Duffy DM, Hsu JTS. Alam M, Nguyen TH, editors. Procedures in cosmetic dermatology series.
8. Duffy MD. Sclerotherapy induced vascular remodeling/neovascularization. Scripta Phlebologica 1998 6 : 52 54.
9. Davis LT, Duffy DM. Determination of incidence and risk factors for postsclerotherapy telangiectatic matting of the lower extremity: a retrospective analysis. J Dermatol Surg Oncol 1990 16 : 327 330.
10. Weiss RA, Feied CF, Weiss MA, editors. Vein diagnosis & treatment: a comprehensive approach.
11. Available from : (accessed January 25, 2010)
12. Almeida JI, Raines JK. FDA approved sodium tetradecyl sulfate (STS) versus compounded STS for venous sclerotherapy. Dermatol Surg 2007 33 : 1037 1044.
13. Rabe E, Schliephake D, Otto J. Polidocanol, sodium tetradecyl sulfate and placebo for sclerotherapy of C1-varicose veins: A double-blind, randomized, controlled clinical trial (EASI-Study). Presented at ACP Marco Island 2008.
14. Ceulen RPM, Sommer A, Vernooy K, et al. Microembolism during foam sclerotherapy of varicose veins. N Engl J Med 2008 358 : 14.
15. Eckmann DM, Kobayashi S, Li M. Microvascular embolization following polidocanol microfoam sclerosant administration. Dermatol Surg 2005 31 : 636 643.
16. Redondo P, Bastarrika G, Sierrra A, et al. Efficacy and safety of microfoam sclerotherapy in a patient with Klippel-Trenaunay syndrome and a patent foramen ovale. Arch Dermatol 2009 145 : 1147 1151.
17. Breu FX, Guggenbichler S. editors European consensus meeting on foam sclerotherapy April 4-6, Tegernsee, Germany. Dermatol Surg 2004 30 : 709 717.
18. Nijsten T, van den Bos RR, Goldman MP, et al. Minimally invasive techniques in the treatment of saphenous varicose veins. J Am Acad Dermatol 2009 60 : 110 119.
19. Goldman MP, Bergan JJ, Guex JJ. Sclerotherapy treatment of varicose and telangiectatic leg veins. 4th Ed.
20. Rao J, Wildemore JK, Goldman MP. Dermatol Surg 2005 31 : 631 635, discussion 635.
21. Bergan JJ., editor. The vein book.
22. Nouri K. Complications in dermatologic surgery.
23. Sigg K. Varizen, ulcus cruris, und thrombose.
24. Henry M. Goldman MP, Bergan JJ, editors. Injection sclerotherapy for varicose veins - a view from Ireland in ambulatory treatment of venous disease: an illustrative guide.
25. Blenkinsopp WK. Choise of sclerosant: an experimental study. Angiologica 1970 7 : 182 186.
26. Sadick N. Manual of sclerotherapy. Lippincott Williams & Wilkins 2000.
27. Marrocco-Trischitta MM, Guerrini P, Abeni D, et al. Reversible cardiac arrest after polidocanol sclerotherapy of peripheral venous malformation. Dermatol Surg 2002 28 : 153 155.
28. Paysant F, Baert A, Morel I, et al. L'Aetoxisclerol accuse a tort D'entrainer une mort subite. Acta Clinica Belgica 2006 61 (Suppl 1) : 51 2.
29. Sylvoz N, Villier C, Blaise S, et al. Polidocanol induced cardiotoxicity. A case report and review of the literature. J Des Maladies Vascularies 2009 33 : 234.
30. Imperiali G, Terruzzi V, Spotti D, et al. Heart failure as a side effect of polidocanol given for esophageal variceal sclerosis. Endoscopy 1986 18 : 207.
31. Paterlini A, Salmi A, Buffoli F, et al. Heart failure and endoscopic sclerotherapy of variceal bleeding. Lancet 1984 2 : 1241.
32. Rabe E, Pannier-Fischer F, Gerlach H, et al. Guidelines for sclerotherapy of varicose veins (ICD 10: 183.0, 183.1, 183.2, and 183.9). Dermatol Surg 2004 30 : 687 693.
33. Mol W, Furukawa H, Sasaki S, et al. Evaluation of the sclerotherapeutic efficacy of ethanol, polidocanol, and OK-432 using an in vitro model. Dermatol Surg 2007 33 : 1452 1459.
34. Freiden IJ, Haggstrom AN, Drolet BA, et al. Infantile hemangiomas: current knowledge, future directions: proceedings of a research workshop on infantile hemangiomas, April 7-9, 2005, Bethesda, Maryland, USA. Pediatr Dermatol 2005 22 : 383 406.
35. Bennett ML, Butte A, Goldman M, et al. Ormshy;ral corticosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation. Arch Dermatol 2001 137 : 1208 1213.
36. Conrad P, Malouf GM, Stacey MC. The Australian Polidocanol (Aethoxysklerol) study. Dermatol Surg 1995 21 : 334 336.
37. Goldman MP. Treatment of varicose and telangiectatic leg veins: double blind prospective comparative trial between aethoxysklerol and sotradecol. Dermatol Surg 2002 28 : 52.
38. Thibault PK. Sclerotherapy of varicose veins and telangiectasias: a 2-year experience with sodium tetradecyl sulphate. Available at : (accessed September 2, 2008).
39. Albino P, et al. Reaction allergique grave apréès traitement de telangiectasies a la glycerine chrome. Phlebologie 2005 58 : 151.
40. Kern P, Ramelet AA, Wutschert R, et al. Single-blind, randomized study comparing chromated glycerin, polidocanol solution, and polidocanol foam for treatment of telangiectatic leg veins. Dermatol Surg 2004 30 : 367 372.
41. Leach B, Goldman MP. Comparative trial between sodium tetradecyl sulfate and glycerin in the treatment of telangiectatic leg veins. Dermatol Surg 2003 29 : 612.
42. Maclaren N, Cowles C, Ozand P, et al. Glycerol intolerance in a child with intermittent hypoglycemia. J Pediatr 86 : 43 9.
43. North American Society of Phlebology. Preliminary results from the North American Society of Phlebology Membership Questionnaire.